FindTrial
Sign In

Evaluation of the effectiveness of Xerolacer artificial saliva in relieving the symptoms of patients with dry mouth after radiotherapy in the head and neck region

Effectiveness of the salivary substitute Xerolacer for symptoms relif of radioinduced xerostomia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5q6h4qb
Enrollment
Unknown
Registered
2021-05-28
Start date
2019-06-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Changes in salivary secretion

Interventions

30 patients with radioinduced xerostomia will be randomized into two groups. The patients in the intervention group will receive the salivary substitute, to rinse the oral cavity three times a day, af
D009067

Sponsors

Faculdade de Odontologia da Universidade de São Paulo
Lead Sponsor
Laboratório Gross - Lacer
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with radioinduced xerostomia.

Exclusion criteria

Exclusion criteria: Patients with normal salivary flow; patients who do not wish to participate in the study; under 18 years of age; pregnant women; lactating; illiterate; incapable.

Design outcomes

Primary

MeasureTime frame
Symptom of dry mouth, assessed by the numerical rating scale.—

Secondary

MeasureTime frame
Oral health related quality of life, assessed by a questionnaire developed for this purpose.;Impact of xerostomia on oral function, assessed by a questionnaire developed for this purpose.—

Countries

Brazil

Contacts

Public ContactCamila de Barros Gallo

Faculdade de Odontologia da Universidade de São Paulo

camilabg@usp.br+551130917883

Outcome results

None listed

Source: REBEC (via WHO ICTRP)